Copyright
©The Author(s) 2023.
World J Gastroenterol. Aug 14, 2023; 29(30): 4671-4684
Published online Aug 14, 2023. doi: 10.3748/wjg.v29.i30.4671
Published online Aug 14, 2023. doi: 10.3748/wjg.v29.i30.4671
Diseases | Total cohort, n = 38090 | Males, n = 23280 | Females, n = 14810 | P value | |||
n, % | Age, yr, mean ± SD | n, % | Age, yr, mean ± SD | n, % | Age, yr, mean ± SD | ||
Total | 100.00 | 57.58 ± 15.79 | 100.00 | 56.26 ± 15.25 | 100.00 | 59.99 ± 16.44 | - |
Diabetes | 26.32 | 56.57 ± 14.60 | 28.94 | 55.43 ± 14.03 | 22.20 | 59.14 ± 15.51 | < 0.001 |
Type I diabetes | 0.79 | 45.33 ± 15.11 | 0.81 | 47.32 ± 12.81 | 0.76 | 42.23 ± 17.70 | 0.591 |
Type II diabetes | 21.84 | 58.04 ± 14.26 | 23.73 | 56.78 ± 13.89 | 18.87 | 60.75 ± 14.66 | < 0.001 |
Secondary diabetes | 2.05 | 50.04 ± 13.24 | 2.71 | 49.35 ± 12.40 | 1.01 | 53.27 ± 16.27 | < 0.001 |
Hypertension | 21.51 | 66.32 ± 14.41 | 20.23 | 64.27 ± 14.43 | 23.51 | 69.36 ± 13.82 | < 0.001 |
Cholelithiasis | 16.79 | 62.33 ± 16.14 | 14.95 | 60.23 ± 15.37 | 19.67 | 64.90 ± 16.68 | < 0.001 |
Dyslipidemia | 16.70 | 51.49 ± 14.28 | 16.76 | 48.57 ± 13.12 | 16.61 | 56.01 ± 14.81 | 0.708 |
Cerebrovascular disease | 12.76 | 69.75 ± 13.34 | 12.19 | 68.52 ± 13.55 | 13.65 | 71.60 ± 12.79 | < 0.001 |
Ischemic cerebrovascular disease | 11.75 | 69.55 ± 13.38 | 11.17 | 68.54 ± 13.57 | 12.65 | 71.09 ± 12.92 | < 0.001 |
Hemorrhagic cerebrovascular disease | 0.34 | 64.05 ± 14.42 | 0.43 | 62.63 ± 14.55 | 0.20 | 69.39 ± 12.79 | < 0.001 |
Fatty liver disease | 12.39 | 49.53 ± 13.50 | 13.46 | 47.20 ± 12.63 | 10.72 | 54.28 ± 13.96 | < 0.001 |
Alcoholic fatty liver disease | 0.35 | 54.07 ± 12.45 | 0.53 | 54.32 ± 12.38 | 0.07 | 50.50 ± 13.39 | < 0.001 |
Coronary heart disease | 10.07 | 72.15 ± 12.77 | 8.37 | 71.13 ± 13.10 | 12.75 | 73.27 ± 12.31 | < 0.001 |
Heart failure | 5.27 | 74.15 ± 13.38 | 4.72 | 72.62 ± 13.98 | 6.14 | 76.06 ± 12.33 | < 0.001 |
Acute pancreatitis | 5.08 | 51.38 ± 15.68 | 6.35 | 52.17 ± 14.18 | 3.07 | 48.80 ± 19.57 | < 0.001 |
Hyperuricemia | 4.93 | 56.86 ± 17.25 | 6.42 | 55.07 ± 16.87 | 2.59 | 64.28 ± 16.85 | < 0.001 |
Ulcer disease | 4.68 | 60.16 ± 14.54 | 5.28 | 59.30 ± 14.06 | 3.73 | 62.22 ± 15.46 | < 0.001 |
Gastric ulcer | 2.17 | 60.34 ± 13.91 | 2.40 | 59.36 ± 13.34 | 1.80 | 62.60 ± 14.92 | < 0.001 |
Duodenal ulcer | 1.30 | 59.15 ± 14.46 | 1.65 | 58.53 ± 14.65 | 0.74 | 61.28 ± 13.62 | < 0.001 |
Liver cirrhosis/fibrosis | 3.49 | 58.70 ± 13.92 | 4.35 | 57.05 ± 13.12 | 2.13 | 65.09 ± 15.04 | < 0.001 |
Alcoholic cirrhosis | 0.72 | 53.23 ± 10.21 | 1.15 | 53.31 ± 10.19 | 0.05 | 49.60 ± 10.54 | < 0.001 |
Pancreatic pseudocyst | 3.45 | 52.55 ± 14.28 | 4.46 | 51.57 ± 12.92 | 1.85 | 56.38 ± 18.17 | < 0.001 |
Malnutrition | 3.36 | 64.04 ± 16.53 | 3.80 | 62.74 ± 15.52 | 2.67 | 66.86 ± 18.23 | < 0.001 |
Gastrointestinal bleeding | 2.93 | 61.76 ± 16.38 | 3.46 | 59.78 ± 15.84 | 2.10 | 67.13 ± 16.64 | < 0.001 |
Pancreatic tumor | 2.65 | 61.43 ± 12.13 | 2.97 | 61.27 ± 11.77 | 2.15 | 61.79 ± 12.89 | < 0.001 |
Malignant tumor of pancreas | 2.36 | 61.74 ± 11.99 | 2.64 | 61.50 ± 11.67 | 1.91 | 62.27 ± 12.65 | < 0.001 |
Osteoporosis | 2.03 | 75.28 ± 13.19 | 1.37 | 70.13 ± 13.89 | 3.06 | 78.02 ± 11.94 | < 0.001 |
Inflammatory bowel disease | 0.14 | 56.13 ± 15.76 | 0.13 | 56.75 ± 14.03 | 0.17 | 55.43 ± 17.76 | 0.388 |
Crohn’s disease | 0.03 | 56.40 ± 14.07 | 0.03 | 58.67 ± 10.76 | 0.03 | 53.00 ± 19.37 | 1 |
Ulcerative enteritis | 0.12 | 56.00 ± 16.05 | 0.11 | 56.15 ± 14.56 | 0.14 | 55.83 ± 17.90 | 0.429 |
- Citation: Cai QY, Tan K, Zhang XL, Han X, Pan JP, Huang ZY, Tang CW, Li J. Incidence, prevalence, and comorbidities of chronic pancreatitis: A 7-year population-based study. World J Gastroenterol 2023; 29(30): 4671-4684
- URL: https://www.wjgnet.com/1007-9327/full/v29/i30/4671.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i30.4671